Metropolitan Life Insurance Company (MetLife)’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,529
| Closed | -$183K | – | 793 |
|
|
2024
Q1 | $183K | Sell |
15,529
-619
| -4% | -$7.92K | 0.01% | 752 |
|
|
2023
Q4 | $229K | Hold |
16,148
| – | – | 0.01% | 679 |
|
|
2023
Q3 | $196K | Buy |
16,148
+1,027
| +7% | +$13.2K | 0.01% | 679 |
|
|
2023
Q2 | $190K | Buy |
15,121
+354
| +2% | +$4.2K | 0.01% | 697 |
|
|
2023
Q1 | $164K | Sell |
14,767
-2,195
| -13% | -$27.1K | 0.01% | 746 |
|
|
2022
Q4 | $207K | Buy |
16,962
+797
| +5% | +$8.97K | 0.01% | 700 |
|
|
2022
Q3 | $169K | Hold |
16,165
| – | – | 0.01% | 741 |
|
|
2022
Q2 | $174K | Hold |
16,165
| – | – | 0.01% | 765 |
|
|
2022
Q1 | $153K | Sell |
16,165
-51,951
| -76% | -$487K | 0.01% | 957 |
|
|
2021
Q4 | $787K | Sell |
68,116
-1,641
| -2% | -$18.3K | 0.01% | 1133 |
|
|
2021
Q3 | $666K | Sell |
69,757
-5,581
| -7% | -$57.1K | 0.01% | 1255 |
|
|
2021
Q2 | $726K | Buy |
75,338
+4,865
| +7% | +$47.5K | 0.01% | 1254 |
|
|
2021
Q1 | $696K | Sell |
70,473
-2,640
| -4% | -$40.9K | 0.01% | 1202 |
|
|
2020
Q4 | $1.69M | Sell |
73,113
-285
| -0.4% | -$5.83K | 0.03% | 562 |
|
|
2020
Q3 | $1.04M | Sell |
73,398
-5,465
| -7% | -$79.7K | 0.02% | 725 |
|
|
2020
Q2 | $1.19M | Buy |
78,863
+1,831
| +2% | +$22.3K | 0.02% | 631 |
|
|
2020
Q1 | $712K | Sell |
77,032
-2,588
| -3% | -$24.6K | 0.01% | 850 |
|
|
2019
Q4 | $775K | Sell |
79,620
-2,192
| -3% | -$20.1K | 0.01% | 1059 |
|
|
2019
Q3 | $656K | Buy |
81,812
+17,835
| +28% | +$194K | 0.01% | 1119 |
|
|
2019
Q2 | $798K | Buy |
63,977
+2,344
| +4% | +$29.7K | 0.01% | 1027 |
|
|
2019
Q1 | $838K | Hold |
61,633
| – | – | 0.02% | 978 |
|
|
2018
Q4 | $590K | Hold |
61,633
| – | – | 0.01% | 1092 |
|
|
2018
Q3 | $745K | Hold |
61,633
| – | – | 0.01% | 1091 |
|
|
2018
Q2 | $963K | Buy |
61,633
+1,049
| +2% | +$15.9K | 0.02% | 940 |
|
|
2018
Q1 | $911K | Buy |
60,584
+8,412
| +16% | +$128K | 0.01% | 943 |
|
|
2017
Q4 | $751K | Sell |
52,172
-58,855
| -53% | -$809K | 0.01% | 1037 |
|
|
2017
Q3 | $1.67M | Buy |
111,027
+8,565
| +8% | +$113K | 0.01% | 999 |
|
|
2017
Q2 | $1.03M | Hold |
102,462
| – | – | 0.01% | 1234 |
|
|
2017
Q1 | $731K | Buy |
102,462
+5,041
| +5% | +$31.9K | 0.01% | 1404 |
|
|
2016
Q4 | $484K | Sell |
97,421
-6,016
| -6% | -$41.6K | ﹤0.01% | 1757 |
|
|
2016
Q3 | $765K | Buy |
103,437
+10,448
| +11% | +$70.6K | 0.01% | 1436 |
|
|
2016
Q2 | $508K | Buy |
92,989
+11,881
| +15% | +$83.1K | ﹤0.01% | 1683 |
|
|
2016
Q1 | $685K | Hold |
81,108
| – | – | 0.01% | 1391 |
|
|
2015
Q4 | $787K | Hold |
81,108
| – | – | 0.01% | 1313 |
|
|
2015
Q3 | $1.14M | Buy |
81,108
+11,789
| +17% | +$185K | 0.01% | 1128 |
|
|
2015
Q2 | $981K | Buy |
+69,319
| New | +$833K | 0.01% | 1295 |
|
Other funds holding FOLD
PA
ACA
RG
Metropolitan Life Insurance Company (MetLife)'s FOLD Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Amicus Therapeutics (FOLD) in Q2 2024, closing a stake of 15,529 shares — an estimated $183K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in FOLD in Q2 2015 and held it in 36 quarters. The position peaked at $1.69M in Q4 2020. 258 funds tracked by Wall St. Rank hold FOLD as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Amicus Therapeutics position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 15,529 Amicus Therapeutics shares in Q2 2024, an estimated $183K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Amicus Therapeutics in Q2 2015 and held it in 36 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Amicus Therapeutics position peaked at $1.69M in Q4 2020.
- 258 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.